Greg Tourangeau - Jul 15, 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Controller
Signature
/s/ Gregory Tourangeau
Stock symbol
FULC
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 04:15 PM
Previous filing
May 10, 2022
Next filing
Feb 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +16.5K $0.00 16.5K Jul 15, 2022 Common Stock 16.5K $5.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 15, 2022 and is is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2022, subject to the reporting person's continued service on each such vesting date.

Remarks:

Exhibit Index: 24.1 Power of Attorney